- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00638846
Performance of Two Silicone Hydrogel Toric Contact Lenses
May 5, 2015 updated by: Johnson & Johnson Vision Care, Inc.
Multi-Center Evaluation Of Two Silicone Hydrogel Toric Contact Lenses
Evaluation of the clinical performance of two toric contact lenses in a 2-week, single masked (subject), daily wear, randomized, bilateral, parallel group study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
276
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arkansas
-
North Little Rock, Arkansas, United States, 72116
- Camp Eye Care Clinic
-
-
California
-
Mission Viejo, California, United States, 92691
- James R. Dugue, O.D.
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80909
- Executive Park Eye Care
-
-
Florida
-
Jacksonville, Florida, United States, 32256
- Dr. Ted Brink and Associates
-
-
Kansas
-
Neodesha, Kansas, United States, 66757
- Grene Vision Group
-
-
Missouri
-
Raytown, Missouri, United States, 64133
- Advanced Eyecare, PC
-
-
New Jersey
-
Florence, New Jersey, United States, 08518
- Dr. James Brobst
-
-
New York
-
Rochester, New York, United States, 14623
- Fine Eye Care Associates
-
-
Ohio
-
Warren, Ohio, United States, 44484
- Warren Ophthalmology Associates
-
-
Pennsylvania
-
Kittanning, Pennsylvania, United States, 16201
- Selden Eyecare LLC
-
State College, Pennsylvania, United States, 16801
- Nittany Eye Associates
-
-
Rhode Island
-
Warwick, Rhode Island, United States, 02886
- Dr. David W. Ferris and Associates
-
-
South Dakota
-
Chamberlain, South Dakota, United States, 57325-0490
- Dr. Larry Menning
-
-
Texas
-
Katy, Texas, United States, 77450
- Wishnow-Sugar Vision Group
-
-
Utah
-
Salt Lake City, Utah, United States, 84106
- Dr. William Bogus
-
-
Virginia
-
Midlothian, Virginia, United States, 23113
- Midlothian Optometric Center
-
Virginia Beach, Virginia, United States, 23455
- The Eye Specialists, Ltd.
-
-
Washington
-
Bremerton, Washington, United States, 98310
- The Eye & Contact Lens Clinic
-
-
Wisconsin
-
Franklin, Wisconsin, United States, 53132
- Matus Eyecare
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be between 18 and 45 years of age.
- Sign Written Informed Consent (See separate document).
- Be an existing successful daily wear toric soft contact lens.
- Require a visual correction in both eyes (monovision or uniocular fitting is NOT allowed).
- Does not require presbyopic correction (can read J1 @ normal reading distance).
- Have a sphere requirement in the range -1.00 and -5.00D (-5.25D refractive)
- Have refractive astigmatism between 0.75D and 2.50D in both eyes.
- Achieve visual acuity of 20/30 or better in each eye with spherical distance correction.
Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having:
- No amblyopia.
- No evidence of lid abnormality or infection.
- No conjunctival abnormality or infection.
- No clinically significant slit lamp findings (i.e. stromal edema, vascularisation, infiltrates or abnormal opacities).
- No other active ocular disease.
Exclusion Criteria:
- Requires concurrent ocular medication.
- Clinically significant (Grade 3 or 4) corneal stromal haze, corneal vascularisation, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear.
- Corneal staining Grade 3 in more than one region.
- Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrolment for this study.
- Abnormal lacrimal secretions.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Keratoconus or other corneal irregularity.
- Polymethyl methacrylate (PMMA) or Rigid Gas Permeable (RGP) lens wear in the previous 8 weeks
- Extended lens wear in last 3 months.
- Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
- Diabetic.
- Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
- Pregnancy, lactating or planning a pregnancy at the time of enrolment.
- Participation in any concurrent clinical trial or in last 60 days.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: senofilcon A toric
senofilcon A, daily wear, toric contact lens worn for two weeks
|
silicone hydrogel toric lens, worn daily for 2 wks (2wks replacement)
Other Names:
|
Active Comparator: balafilcon A toric
balafilcon A, daily wear, toric contact lens worn for two weeks
|
silicone hydrogel toric lens, worn daily for 2 wks (2wks replacement)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lens Orientation
Time Frame: 1 minute after insertion
|
Proportion of eyes with lens orientation within 5 degrees of optimal
|
1 minute after insertion
|
Lens Stability
Time Frame: 10-15 minutes after insertion
|
Lens stability is measured as the amount of rotation induced from blink after the lens has settled.
|
10-15 minutes after insertion
|
Subjective Comfort
Time Frame: 2 weeks of lens wear
|
Subjective comfort was derived from a weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response.
>0 = comfortable, < 0 = uncomfortable.
Combined measures from Week 1 and Week 5.
|
2 weeks of lens wear
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to Fit Lens
Time Frame: after lens insertion
|
Time required for the optometrist to fit the lens.
|
after lens insertion
|
Subjective Lens Vision
Time Frame: measured at 1 and 2 weeks
|
A weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1 = most negative response to 5 = most positive response was used to derive vision outcomes.
>0 = satisfactory vision, < 0 = unsatisfactory vision.
Analysis is performed on combined 1 week and 2 week data.
|
measured at 1 and 2 weeks
|
Overall Corneal Staining
Time Frame: After 2 weeks use
|
National Eye Institute 0-3 Scale: Grade 0 = Normal, Grade 1 = Mild, superficial stippling, Grade 2 = Moderate, punctuate staining including superficial abrasion of the cornea, Grade 3 = Severe, abrasion or corneal erosion, deep corneal abrasion or recurrent erosion.
|
After 2 weeks use
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Graeme YOung, MPhil PhD
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2008
Primary Completion (Actual)
May 1, 2008
Study Completion (Actual)
May 1, 2008
Study Registration Dates
First Submitted
March 10, 2008
First Submitted That Met QC Criteria
March 10, 2008
First Posted (Estimate)
March 19, 2008
Study Record Updates
Last Update Posted (Estimate)
May 21, 2015
Last Update Submitted That Met QC Criteria
May 5, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- CR-0801
- CTOR-501
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vision Correction
-
Johnson & Johnson Vision Care, Inc.CompletedVision CorrectionUnited States, Canada
-
Contamac LtdCompletedVision CorrectionUnited Kingdom
-
Johnson & Johnson Vision Care, Inc.CompletedVision CorrectionUnited States, United Kingdom
-
Innovative MedicalCompletedVision CorrectionUnited States
-
FORSIGHT Vision3CompletedPost Laser Vision Correction Pain and DiscomfortUnited States
-
GE HealthcareCompletedImage CorrectionUnited States
-
LG ChemCompleted
-
Galderma R&DCompleted
-
LG Life SciencesCompletedCorrection of Nasolabial Folds
-
LG Life SciencesCompletedCorrection of Nasolabial FoldsChina
Clinical Trials on senofilcon A toric
-
Johnson & Johnson Vision Care, Inc.Foresight Regulatory Strategies, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.CompletedAstigmatismUnited Kingdom
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.Completed
-
Johnson & Johnson Vision Care, Inc.Foresight Regulatory Strategies, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedAstigmatismAustralia, United States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Coopervision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedAstigmatismUnited Kingdom